ArticleBioinformation2024
The role of extra-corporeal radiation therapy for osteo-sarcoma.
Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal radiation therapy is a new limb-salvaging procedure increasingly used, especially in situations where it may not be possible to carry out complete surgical resection. Osteosarcoma is a malignant tumour of bone that, typically, presents in young people, and often, it is managed by using different modes of treatment, which include surgery and chemotherapy. This therapy involves the removal of the involved segment of bone, its extracorporeal irradiation, followed by re-implantation to preserve limb function and reduce the risk of recurrence. Therefore, it is of interest to review the effectiveness of, clinical uses, and results of ECRT, focusing on its benefits in terms of bony conservation and decreased complications with either prosthetics or allografts. Promising local control and survival rates further cement its potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.